<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Sutureless and glue free conjunctival auto grafting after pterygium excision]]></title>

                                    <author><![CDATA[MK Goswami]]></author>
                                    <author><![CDATA[Md Asaduzzaman]]></author>
                
                <link data-url="https://imcjms.com/registration/journal_full_text/142">
    https://imcjms.com/registration/journal_full_text/142
</link>
                <pubDate>Sat, 12 Nov 2016 17:22:20 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[IMC J Med Sci 2016; 10(2): 36-38]]></comments>
                <description>Abstract
Background and
objectives:&amp;nbsp;Suture or glue has been used
to secure the conjunctival auto graft after excision of the pterygium.
Recently, auto grafting using patient’s own blood as a bioadhesive to secure
the graft in position has been described by several authors. Therefore, the present
study was undertaken to determine the outcome of excision of pterygium and
sutureless conjunctival auto graft using patients’ own blood as a bioadhesive.
Methods: Patients with primary and recurrent pterygium attending the
Department of Ophthalmology of Bangladesh Institute of Research, Rehabilitation in
Diabetes, Endocrine and Metabolic Disorders (BIRDEM) hospital from March 2014 to July 2015 were included in the study. Pterygium
was excised and conjunctival auto graft was applied. Grafts were secured to the pterygium excision area with auto
blood fibrin clot. All
patients were examined after 48 hr and followed for 1, 4 and 12 weeks for graft
dislodgement, sub-conjunctival hemorrhage, graft recession, graft edema and recurrence
of pterygium.
Results:&amp;nbsp;A total of 35 primary and 2 recurrent
pterygium cases were included in the study. The
mean operation time was 15±1 minutes. Out of 37 eyes 5 (13.5%) had
subconjunctival hemorrhage and 2 (5.4%) had graft recession and edema after 48hrs
of operation. At 3 months follow up, 2 cases (5.4%) of graft recession and no
case of recurrence of pterygium was found. 
Conclusion:&amp;nbsp;Pterygium excision and conjunctival auto graft without
sutures appears to be an effective treatment modality for primary and recurrent
pterygium with no additional cost.
IMC J Med Sci 2016; 10(2): 36-38.&amp;nbsp;DOI: https://doi.org/10.3329/imcjms.v10i2.31106  
Address for
Correspondence: Dr.
Manash Kumar Goswami, Associate Professor, Department of Ophthalmology, BIRDEM
General Hospital,&amp;nbsp; 122 Kazi Nazrul Islam
Avenue, Shahbag, Dhaka. Email: manashkg@yahoo.com
&amp;nbsp;
&amp;nbsp;
Introduction 
A pterygium is a winged
shaped growth of fibrovascular conjunctiva onto the cornea. Its incidence
varies across geographical locations and several hypotheses have been ascribed
to its etiology [1]. Currently, it is believed that the pterygium is a growth
disorder characterized by corneal conjunctivalization due to exposure to ultraviolet
light and microtrauma. Ultraviolet light induced localized stem cell
dysfunction is possibly related to the formation of pterygium [2].
The indications for
surgery include reduced vision due to encroachment of visual axis and irregular
astigmatism, chronic irritation, recurrent inflammation and restriction of
ocular motility and cosmetics. Numerous surgical techniques including bare
sclera excision, with and without the use of adjuncts like beta irradiation,
thiotepa eye drops, intra or postoperative mitomycin C or anti neoplastic
agents, amniotic membrane transplantation, conjunctival auto graft with or
without limbal stem cells have been described [3]. In conjunctival auto
grafting after pterygium excision, the conjunctival graft is usually sutured or
glued to the bed to secure its position. In sutureless glue free auto grafting
technique, the conjunctival graft is placed on to the bed where the oozing
blood clots and forms a bioadhesive, which secures the graft in its position [4].
Auto graft with suturing is more cumbersome to perform and causes postoperative
irritation and discomfort to the patient. The procedure also takes longer time
to perform. On the other hand, if glue is used instead of suture, there are
chances of hypersensitivity reaction and it is expensive. The new technique of sutureless
auto grafting where blood clot is used as a bioadhesive is free from the above
disadvantages.
To the best of our
knowledge, this technique has not yet been applied in Bangladesh. Therefore, the present
study was undertaken to evaluate the outcome of the technique of excision of
pterygium and sutureless conjunctival auto graft using patients’ own blood as a
bioadhesive. 
&amp;nbsp;
Materials methods
Selected patients with
diagnosis of pterygium attending the Department of Ophthalmology of Bangladesh
Institute of Research, Rehabilitation in Diabetes, Endocrine and Metabolic
Disorders (BIRDEM) General hospital from
March 2014 to July 2015 were
included in the study. The study was approved by the Ethical Review Board of
BADAS. Informed written consent was obtained from each participant. 
&amp;nbsp;
Surgical technique
All surgical procedures
were done under peribulbar anesthesia. Pterygium was excised without
application of cautery to the scleral bed. Blood was allowed to ooze and form a
clot on the bed. A caliper was used to measure the size of the conjunctival
auto graft. One millimeter over sized graft compared to the pterygium bed was
created from upper temporal conjunctiva. Tenon’s capsule or limbal tissue was
not included. The auto graft was then glided into place over the bare sclera in
the correct anatomical orientation and conjunctival edges were apposed with non
tooth forceps. Donor area was left as it is for re-epithelization. At the end of
the surgery, eye speculum was carefully removed without distorting the graft.
Eye was patched for 48 hours.
All patients were given
1% prednisolone acetate eye drops 4-6 times daily and moxifloxacin eye drops
for 15 days. Lubricating eye drops for 6-8 weeks were prescribed. Patients were
followed up at48hrs,1,4and12weeksforgraftdislodgement,
sub-conjunctival hemorrhage, graft recession, graft edema and recurrence of pterygium.

&amp;nbsp;
Results
A total of 35 cases
were included in the study. The mean age of the study population was 32±2
years. The male and female distribution was 30 and 05 respectively. The detail
profile of the study population is shown in Table-1. All the patients were
examined after 24-36 hrs following operation for graft dislodgement, recession,
edema sub-conjunctival hemorrhage. Out of 37 eyes only 5 (13.5%) had
subconjunctival hemorrhage and 2 (5.4%) had graft recession and edema after 48 hrs
of operation. Two cases (5.4%) of graft recession were noted at 3 month follow
up. There was no recurrence of pterygium (Table-2). The mean operation time was
15±1 minutes.
&amp;nbsp;
Table-1: Profile of the study population
&amp;nbsp;

 
  
  Outcome 
  
  
  Number
  (%)
  n=37
  
 
 
  
  After
  48 hrs
  Graft dislodgement
  Sub-conjunctival hemorrhage 
  Graft recession
  Graft edema
  &amp;nbsp;
  After
  12 weeks 
  Graft dislodgement
  Sub-conjunctival hemorrhage 
  Graft recession
  Graft edema
  Pterygium recurrence
  
  
  &amp;nbsp;
  0 (0)
  5 (13.5)
  2 (5.4)
  2 (5.4)
  &amp;nbsp;
  &amp;nbsp;
  0 
  0
  2
  0
  0
  
 

&amp;nbsp;
Discussion
Pterygium surgery
should ideally have a low or no recurrence, minimal complications and be cosmeticallyacceptable.Severalsurgical
techniques
have evolved over the years with recurrence rates varying from 2 to 88% [4]. Surgical
procedures like bare sclera technique introduced in 1960’s, though easy to do, has
been abandoned due to very high recurrence rate in the range of 26.8 to 88%
[4]. Application of intra operative mitomycin C has a recurrence of 0-43% with
devastating ocular complications like sclera melt, ocular perforation, etc [5].
During 1980’s conjunctival auto graft has been introduced and currently is the
standard procedure for pterygium surgery with low recurrence rates in the range
of 0-9% [6]. Procedure involves thin conjunctival graft either with or without
limbal tissue which is sutured to the graft area. It has good cosmetic result
having no serious intraoperative complications. However, the procedure takes
longer surgical time and there is suture related complications. During the
present decade, fibrin glue application to fix the graft was developed with
elimination of suture related complications and faster surgery [7]. But it has
other drawback like increased cost, availability, anaphylactic reactions, bio
degradability of glue within 3 hours of grafting and recurrence rate of 10-15%
[8]. 
Recent introduction of
auto graft technique using patient’s own blood as bioadhesive substance on the
excised bed of the pterygium has gained popularity. The technique has eliminated
several disadvantages encountered with earlier methods. It has minimized the
surgical time, trauma to the conjunctiva and recurrence rate. In our series,
the operation time was only 14 to 16 minutes and there was no single case of pterygium
recurrence after 3 months of surgery though we had 2 cases of graft recession.
There was no other complication observed in our cases. The result was
comparable to other studies with similar techniques [9]. The technique is cost
effective and easy to perform with less discomfort to patient. However, our
series had short follow up period of 3 months and did not have different types
of atypical pterygia. 
Sutureless and glue free
conjunctival auto graft using blood clot as a bioadhesive is a useful
alternative method for graft fixation in pterygium surgery. We found the new
procedure of auto grafting free of any untoward complications.
&amp;nbsp;
Reference
1.&amp;nbsp;&amp;nbsp; Hirst LW. Distribution, risk factors and
epidemiology of pterygium. In Hugh R. Taylor (Ed.), Pterygium. The Netherlands:
Kugler Publications; 2000. p. 15-27.
2.&amp;nbsp;&amp;nbsp; Dushku
N, Reid TW. Immunohistochemical evidence that human pterygia originates from an
invasion of vimentin -expressing altered limbal epithelial basal cells- Curr
Eye Res 1994; 13(7): 473-81.
3.&amp;nbsp;&amp;nbsp; Hirst LW. The treatment of pterygium. Surv Ophthalmology 2003; 48(2): 145-180.
4.&amp;nbsp;&amp;nbsp; Singh PK, Sing S, Vays C, Sing M. Conjunctival
auto grafting without fibrin glue or sutures for pterygium surgery. Cornea 2013; 32(1): 104-107.
5.&amp;nbsp;&amp;nbsp; Ang
LP, Chua
JL, Tan
DT. Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 2007; 18(4): 308-313. 
7.&amp;nbsp;&amp;nbsp; Marticorena
J, Rodríguez-Ares
MT, Touriño
R, Mera
P, Valladares
MJ, Martinez-de-la-Casa
JM, Benitez-del-Castillo
JM. Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea 2006; 25(1): 34-36.
</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
